nifekalant hydrochloride has been researched along with amiodarone in 22 studies
| Studies (nifekalant hydrochloride) | Trials (nifekalant hydrochloride) | Recent Studies (post-2010) (nifekalant hydrochloride) | Studies (amiodarone) | Trials (amiodarone) | Recent Studies (post-2010) (amiodarone) |
|---|---|---|---|---|---|
| 138 | 16 | 38 | 8,156 | 743 | 1,889 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (9.09) | 18.2507 |
| 2000's | 8 (36.36) | 29.6817 |
| 2010's | 12 (54.55) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Masuda, Y; Mori, K; Nakaya, H; Saito, T | 1 |
| Aizawa, Y; Naitoh, N; Takahashi, K; Washizuka, T | 1 |
| Ohnishi, S | 1 |
| Ito, H; Maruyama, T | 1 |
| Honjo, H; Ishiguro, Y; Kamiya, K; Kodama, I; Nakagawa, H; Okuno, Y; Sakuma, I; Yamazaki, M | 1 |
| Fujiki, A | 1 |
| Sugi, K | 1 |
| Arakaki, T; Isomoto, S; Kawakami, A; Ono, K; Yamashita, S; Yano, K | 1 |
| Maeda, K; Nakagawa, E; Takagi, M; Tatsumi, H; Yoshiyama, M | 1 |
| Abe, A; Ikeda, T; Ishiguro, H; Mera, H; Miwa, Y; Miyakoshi, M; Shimizu, H; Tsukada, T; Yoshino, H; Yusu, S | 1 |
| Akieda, K; Amino, M; Fujibayashi, D; Fukushima, T; Hashida, T; Higami, S; Inokuchi, S; Kodama, I; Morita, S; Opthof, T; Otsuka, H; Shima, M; Tamura, K; Tanabe, T; Uemura, S; Yoshioka, K | 1 |
| Cong, LH; Ji, XF; Li, CS; Wang, S; Yang, L | 1 |
| Furutani, K; Inanobe, A; Iwata, M; Kurachi, Y; Ohno, Y; Yamakawa, Y | 1 |
| Hirayama, A; Kofune, M; Kogawa, R; Mano, H; Nakai, T; Ohkubo, K; Okumura, Y; Sasaki, N; Sonoda, K; Watanabe, I | 1 |
| Aibara, K; Goto, K; Harayama, N; Isa, Y; Kamochi, M; Nagata, K; Nihei, S; Sata, T | 1 |
| Iacovidou, N; Karlis, G; Lelovas, P; Mentzelopoulos, S; Niforopoulou, P; Papalois, A; Siafaka, I; Xanthos, T | 1 |
| Amino, M; Funakoshi, H; Hayakawa, K; Ikari, Y; Inokuchi, S; Matsuzaki, M; Morimura, N; Nagao, K; Nakagawa, Y; Sakurai, A; Tahara, Y; Yaguchi, A; Yonemoto, N; Yoshioka, K | 1 |
| Aibara, K; Harayama, N; Kamochi, M; Nagata, K; Nihei, S; Sata, T | 1 |
| Fukuda, R; Fushimi, K; Ishinokami, S; Kitahashi, A; Matsui, H; Oyanagi, M; Tagami, T; Unemoto, K; Yasunaga, H | 1 |
| Koyfman, A; Long, B | 1 |
| Tagami, T; Yasunaga, H; Yokota, H | 1 |
| Chuma, M; Imai, T; Ishizawa, K; Izawa-Ishizawa, Y; Koga, T; Kondo, Y; Koyama, T; Kurata, Y; Nakura, H; Niimura, T; Sato, S; Sendo, T; Takechi, K; Tanaka, S; Zamami, Y | 1 |
9 review(s) available for nifekalant hydrochloride and amiodarone
| Article | Year |
|---|---|
[Management of lethal ventricular arrhythmias after cardiac surgery].
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Catheter Ablation; Humans; Intra-Aortic Balloon Pumping; Postoperative Complications; Pyrimidinones; Recurrence; Tachycardia, Ventricular; Ventricular Fibrillation | 2002 |
[Recent findings on the dromotropic actions of the class III antiarrhythmic agents].
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Neural Conduction; Pyrimidinones; Sotalol | 2002 |
Optical imaging of spiral waves: pharmacological modification of spiral-type excitations in a 2-dimensional layer of ventricular myocardium.
Topics: Amiodarone; Animals; Anisotropy; Anti-Arrhythmia Agents; Heart Conduction System; Humans; Myocardium; Pre-Excitation Syndromes; Pyrimidinones; Signal Processing, Computer-Assisted; Sodium Channel Blockers; Tachycardia, Ventricular | 2005 |
[Present status in and prospects for anti-arrhythmic drug therapy: How to use type III anti-arrhythmic agents].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bepridil; Drug Therapy, Combination; Humans; Pyrimidinones; Sotalol | 2006 |
[Strategy for cardiac arrhythmias in acute coronary syndrome].
Topics: Amiodarone; Angina, Unstable; Anti-Asthmatic Agents; Aprindine; Atrial Fibrillation; Bepridil; Electric Countershock; Humans; Myocardial Infarction; Potassium Channel Blockers; Pyrimidinones; Recurrence; Syndrome; Tachycardia, Ventricular; Ventricular Fibrillation | 2006 |
[Drug Therapy for Shock-Resistant Ventricular Fibrillation: Comparison of Nifekalant and Amiodarone].
Topics: Amiodarone; Anti-Asthmatic Agents; Defibrillators; Humans; Injections, Intravenous; Potassium Channel Blockers; Pyrimidinones; Ventricular Fibrillation | 2016 |
Best Clinical Practice: Emergency Medicine Management of Stable Monomorphic Ventricular Tachycardia.
Topics: Amiodarone; Anti-Arrhythmia Agents; Electric Countershock; Electrocardiography; Emergency Service, Hospital; Evidence-Based Medicine; Humans; Lidocaine; Procainamide; Pyrimidinones; Review Literature as Topic; Sotalol; Tachycardia, Ventricular | 2017 |
Antiarrhythmic drugs for out-of-hospital cardiac arrest with refractory ventricular fibrillation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Emergency Medical Services; Humans; Intensive Care Units; Lidocaine; Out-of-Hospital Cardiac Arrest; Placebos; Pyrimidinones; Ventricular Fibrillation | 2017 |
Meta-analysis of the efficacies of amiodarone and nifekalant in shock-resistant ventricular fibrillation and pulseless ventricular tachycardia.
Topics: Amiodarone; Humans; Publication Bias; Pulse; Pyrimidinones; Randomized Controlled Trials as Topic; Survival Analysis; Tachycardia, Ventricular; Treatment Outcome; Ventricular Fibrillation | 2017 |
3 trial(s) available for nifekalant hydrochloride and amiodarone
| Article | Year |
|---|---|
The effects of nifekalant hydrochloride on the QT dispersion after direct-current defibrillation.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Anti-Arrhythmia Agents; Defibrillators, Implantable; Electrocardiography; Female; Humans; Male; Middle Aged; Pyrimidinones; Sotalol; Tachycardia, Ventricular; Ventricular Fibrillation; Ventricular Function, Left | 2008 |
Effects of intravenous nifekalant as a lifesaving drug for severe ventricular tachyarrhythmias complicating acute coronary syndrome.
Topics: Acute Coronary Syndrome; Aged; Amiodarone; Anti-Arrhythmia Agents; Blood Pressure; Electrocardiography; Emergency Medical Services; Female; Heart Rate; Humans; Infusions, Intravenous; Injections, Intravenous; Lidocaine; Male; Middle Aged; Pyrimidinones; Tachycardia, Ventricular; Torsades de Pointes; Ventricular Fibrillation | 2009 |
Comparative study of nifekalant versus amiodarone for shock-resistant ventricular fibrillation in out-of-hospital cardiopulmonary arrest patients.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Drug Therapy, Combination; Electric Countershock; Emergency Service, Hospital; Female; Heart Arrest; Heart Diseases; Humans; Male; Middle Aged; Prognosis; Pyrimidinones; Survival Analysis; Treatment Outcome; Ventricular Fibrillation | 2010 |
10 other study(ies) available for nifekalant hydrochloride and amiodarone
| Article | Year |
|---|---|
Effects of class III antiarrhythmic drugs on the Na(+)-activated K+ channels in guinea-pig ventricular cells.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Dose-Response Relationship, Drug; Guinea Pigs; Heart Ventricles; In Vitro Techniques; Ouabain; Patch-Clamp Techniques; Piperidines; Potassium Channels; Pyridines; Pyrimidinones; Sodium | 1996 |
Effects of class I and III antiarrhythmic drugs on ventricular tachycardia-interrupting critical paced cycle length with rapid pacing.
Topics: Adolescent; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Child; Electrophysiology; Female; Heart Conduction System; Humans; Male; Middle Aged; Piperidines; Pyridines; Pyrimidinones; Tachycardia, Ventricular | 1998 |
Effects of antiarrhythmic drugs on apoptotic pathways in H9c2 cardiac cells.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Apoptosis; Caspases; Cell Line; Clone Cells; Diploidy; DNA Fragmentation; Dose-Response Relationship, Drug; Lidocaine; Membrane Potentials; Mitochondrial Membranes; Propranolol; Pyrimidinones; Signal Transduction; Time Factors; Verapamil | 2006 |
Comparison of the efficacy of nifekalant and amiodarone in a porcine model of cardiac arrest.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Cardiopulmonary Resuscitation; Disease Models, Animal; Dose-Response Relationship, Drug; Heart Arrest; Heart Rate; Male; Pyrimidinones; Swine; Treatment Outcome; Ventricular Fibrillation; Ventricular Function | 2010 |
A mechanism underlying compound-induced voltage shift in the current activation of hERG by antiarrhythmic agents.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Hydantoins; Imidazolidines; Membrane Potentials; Piperazines; Pyrimidinones; Xenopus laevis | 2011 |
Rate-dependent electrophysiologic effects of the class III antiarrhythmic drugs nifekalant, amiodarone, and ibutilide on the atrium in patients with persistent atrial fibrillation.
Topics: Action Potentials; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Pacing, Artificial; Female; Heart Atria; Heart Conduction System; Humans; Male; Middle Aged; Pyrimidinones; Sulfonamides | 2013 |
Comparison of nifekalant and amiodarone for resuscitation of out-of-hospital cardiopulmonary arrest resulting from shock-resistant ventricular fibrillation.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiopulmonary Resuscitation; Dose-Response Relationship, Drug; Electric Countershock; Female; Humans; Male; Middle Aged; Out-of-Hospital Cardiac Arrest; Prospective Studies; Pyrimidinones; Retrospective Studies; Ventricular Fibrillation | 2014 |
Nifekalant Versus Amiodarone in the Treatment of Cardiac Arrest: an Experimental Study in a Swine Model of Prolonged Ventricular Fibrillation.
Topics: Amiodarone; Animals; Blood Pressure; Cardiopulmonary Resuscitation; Disease Models, Animal; Electric Countershock; Epinephrine; Female; Heart Arrest; Heart Rate; Pyrimidinones; Survival Analysis; Swine; Ventricular Fibrillation | 2015 |
Nifekalant Hydrochloride and Amiodarone Hydrochloride Result in Similar Improvements for 24-Hour Survival in Cardiopulmonary Arrest Patients: The SOS-KANTO 2012 Study.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Female; Humans; Japan; Male; Middle Aged; Out-of-Hospital Cardiac Arrest; Pyrimidinones; Survival Rate; Treatment Outcome | 2015 |
Amiodarone or nifekalant upon hospital arrival for refractory ventricular fibrillation after out-of-hospital cardiac arrest.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Emergency Medical Services; Female; Hospital Mortality; Hospitalization; Humans; Male; Middle Aged; Out-of-Hospital Cardiac Arrest; Pyrimidinones; Retrospective Studies; Ventricular Fibrillation; Young Adult | 2016 |